Miloslav Beran Selected Research

Miloslav Beran Research Topics

Disease

19	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2013 - 01/2002
16	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2008 - 01/2002
10	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2008 - 05/2002
9	Leukemia 12/2006 - 05/2002
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2006 - 06/2002
5	Neoplasms (Cancer) 04/2015 - 01/2002
5	Philadelphia Chromosome 03/2006 - 05/2002
4	Blast Crisis (Blast Phase) 05/2008 - 02/2005
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 04/2010 - 06/2002
3	Myeloproliferative Disorders (Myeloproliferative Disorder) 11/2007 - 09/2003
3	Acute Promyelocytic Leukemia 12/2006 - 06/2002
3	Hematologic Neoplasms (Hematological Malignancy) 12/2006 - 01/2002
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2005 - 06/2002
2	Fever (Fevers) 01/2008 - 01/2003
2	Chromosome Aberrations (Chromosome Abnormalities) 02/2006 - 05/2004
2	Pathologic Complete Response 06/2004 - 06/2002
2	Anemia 10/2002 - 06/2002
1	Breast Neoplasms (Breast Cancer) 04/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2008
1	Cardiotoxicity 05/2008
1	Exanthema (Rash) 01/2008
1	Ataxia (Dyssynergia) 01/2008
1	Diarrhea 01/2008
1	Nausea 01/2008
1	Fatigue 01/2008
1	Polycythemia Vera 11/2007
1	Essential Thrombocythemia 11/2007
1	Neutropenia 04/2007
1	Multiple Myeloma 12/2006
1	Mucositis 07/2006
1	Hypertension (High Blood Pressure) 07/2006
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2006
1	Abnormal Karyotype 03/2006
1	Mediastinal Diseases 09/2004
1	Central Nervous System Diseases (CNS Diseases) 09/2004

Drug/Important Bio-Agent (IBA)

12	Imatinib Mesylate (Gleevec)FDA Link 05/2008 - 05/2002
7	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2006 - 05/2002
5	Biological ProductsIBA 04/2010 - 08/2002
4	Topotecan (Hycamtin)FDA LinkGeneric 03/2006 - 12/2002
4	Proteins (Proteins, Gene)FDA Link 04/2004 - 07/2002
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2013 - 06/2002
3	fludarabineIBA 06/2005 - 04/2004
3	NucleosidesIBA 02/2005 - 12/2003
3	Gemtuzumab (Mylotarg)FDA Link 12/2002 - 06/2002
2	Phosphotransferases (Kinase)IBA 05/2008 - 03/2006
2	Clofarabine (Clolar)FDA Link 07/2006 - 02/2005
2	Hemoglobins (Hemoglobin)IBA 03/2006 - 10/2002
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2005 - 05/2002
2	nilotinib FDA Link 09/2005 - 07/2005
2	2-aminopyrimidineIBA 09/2005 - 07/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2005 - 12/2004
2	Rituximab (Mabthera)FDA Link 06/2005 - 05/2003
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2004 - 01/2004
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 06/2002 - 06/2002
1	Tyrosine (L-Tyrosine)FDA Link 06/2010
1	bardoxolone methylIBA 05/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2008
1	Glutathione (Reduced Glutathione)IBA 05/2008
1	BilirubinIBA 01/2008
1	tipifarnib (R115777)IBA 01/2008
1	Transaminases (Aminotransferases)IBA 01/2008
1	Interferon-alpha (Interferon Alfa)IBA 11/2007
1	CholesterolIBA 04/2007
1	Cytotoxins (Cytolysins)IBA 04/2007
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 04/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2007
1	LDL CholesterolIBA 04/2007
1	Triglycerides (Triacylglycerol)IBA 04/2007
1	ArsenicIBA 12/2006
1	Arsenic Trioxide (Trisenox)FDA Link 12/2006
1	Arsenicals (Arsenic Compounds)IBA 12/2006
1	Axitinib (AG 013736)IBA 07/2006
1	Pharmaceutical PreparationsIBA 07/2006
1	NSC 680410IBA 03/2006
1	SurvivinIBA 02/2006
1	Janus Kinase 2IBA 11/2005
1	TransferasesIBA 04/2005
1	7- cyano- 2,3,4,5- tetrahydro- 1- (1H- imidazol- 4- ylmethyl)- 3- (phenylmethyl)- 4- (2- thienylsulfonyl)- 1H- 1,4- benzodiazepine (BMS 214662)IBA 04/2005
1	Vincristine (Oncovin)FDA LinkGeneric 12/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2004
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2004
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2004
1	Monoclonal AntibodiesIBA 09/2004
1	beta 2-Microglobulin (beta 2 Microglobulin)IBA 09/2004
1	bcr-abl Fusion ProteinsIBA 06/2004
1	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2004
1	fms-Like Tyrosine Kinase 3IBA 05/2004
1	lestaurtinibIBA 05/2004
1	Alkylating AgentsIBA 05/2004
1	laromustine (VNP40101M)IBA 05/2004
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 05/2004
1	flt3 ligand protein (flt3 ligand)IBA 01/2004
1	formal glycol (dioxolane)IBA 12/2003
1	troxacitabineIBA 12/2003
1	Bortezomib (Velcade)FDA Link 08/2003
1	Alemtuzumab (Campath)FDA Link 05/2003

Therapy/Procedure

10	Therapeutics 04/2015 - 01/2003
8	Drug Therapy (Chemotherapy) 01/2013 - 05/2004
1	Intravenous Infusions 02/2005
1	Radiotherapy 09/2004